APELLIS.COM: Keyword Density Checker

Total words: 758 | 2-word phrases: 199 | 3-word phrases: 208 | 4-word phrases: 212

PAGE INFO

Title	Try to keep the title under 60 characters (90 characters) Official Home Page of the Apellis Pharmaceuticals Corporate Site \| Apellis Pharmaceuticals
Description	Try to keep the meta description between 50 - 160 characters (279 characters) Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (33 characters) Courageous Science + Compassion

#	Keyword	Frequency	Density
1	healthcare providers for	2	0.96%
2	our culture benefits	2	0.96%
3	focus areas ophthalmology	2	0.96%
4	areas ophthalmology rare	2	0.96%
5	ophthalmology rare disease	2	0.96%
6	rare disease research	2	0.96%
7	disease research our	2	0.96%
8	providers for patients	2	0.96%
9	products careers our	2	0.96%
10	careers our culture	2	0.96%
11	culture benefits open	2	0.96%
12	clinical trials focus	2	0.96%
13	open positions investorsmedia	2	0.96%
14	overview stock information	2	0.96%
15	stock information news	2	0.96%
16	information news releases	2	0.96%
17	news releases perspectives	2	0.96%
18	presentations corporate governance	2	0.96%
19	corporate governance financialsfilings	2	0.96%
20	governance financialsfilings investor	2	0.96%
21	visit us on	2	0.96%
22	trials focus areas	2	0.96%
23	benefits open positions	2	0.96%
24	about us who	2	0.96%
25	corporate giving our	2	0.96%
26	we are our	2	0.96%
27	are our team	2	0.96%
28	our team board	2	0.96%
29	us who we	2	0.96%
30	broad range of	2	0.96%

#	Keyword	Frequency	Density
1	healthcare providers for patients	2	0.94%
2	our culture benefits open	2	0.94%
3	trials focus areas ophthalmology	2	0.94%
4	focus areas ophthalmology rare	2	0.94%
5	areas ophthalmology rare disease	2	0.94%
6	ophthalmology rare disease research	2	0.94%
7	rare disease research our	2	0.94%
8	products careers our culture	2	0.94%
9	culture benefits open positions	2	0.94%
10	of c3 our pipeline	2	0.94%
11	benefits open positions investorsmedia	2	0.94%
12	overview stock information news	2	0.94%
13	stock information news releases	2	0.94%
14	information news releases perspectives	2	0.94%
15	presentations corporate governance financialsfilings	2	0.94%
16	corporate governance financialsfilings investor	2	0.94%
17	clinical trials focus areas	2	0.94%
18	careers our culture benefits	2	0.94%
19	science of c3 our	2	0.94%
20	directors corporate giving our	2	0.94%
21	science science of c3	2	0.94%
22	us who we are	2	0.94%
23	who we are our	2	0.94%
24	we are our team	2	0.94%
25	are our team board	2	0.94%
26	about us who we	2	0.94%
27	corporate giving our science	2	0.94%
28	giving our science science	2	0.94%
29	our science science of	2	0.94%
30	on twitter visit us	1	0.47%
31	a better way join	1	0.47%
32	we challenge conventional thinking	1	0.47%
33	challenge conventional thinking and	1	0.47%
34	always question if theres	1	0.47%
35	question if theres a	1	0.47%
36	if theres a better	1	0.47%
37	theres a better way	1	0.47%
38	better way join the	1	0.47%
39	us on twitter visit	1	0.47%
40	next our pipeline we	1	0.47%